Details for 2018810153
Up to date per 03.04.2026
Actions
Details for 2018810153
Granted/Registered
European Patent
15.04.2020 A
31.07.2024 B1
31.05.2017
US
201762513251 P
A61K 36/47 20060101AFI20240403BHEP
Owner
Napo Pharmaceuticals, Inc.200 Pine Street, Suite 400 San Francisco, CA 94104US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
CONTE, Lisa, A.301 Main St. Apt. 30G San Francisco CA 94105US
CHATURVEDI, Pravin, R.27 Jenkins Rd. Andover MA 01810US
Information about Fees